Success Metrics

Clinical Success Rate
89.5%

Based on 17 completed trials

Completion Rate
89%(17/19)
Active Trials
0(0%)
Results Posted
18%(3 trials)
Terminated
2(10%)

Phase Distribution

Ph phase_2
1
5%
Ph not_applicable
3
14%
Ph phase_3
5
24%
Ph phase_1
8
38%
Ph phase_4
4
19%

Phase Distribution

8

Early Stage

1

Mid Stage

9

Late Stage

Phase Distribution21 total trials
Phase 1Safety & dosage
8(38.1%)
Phase 2Efficacy & side effects
1(4.8%)
Phase 3Large-scale testing
5(23.8%)
Phase 4Post-market surveillance
4(19.0%)
N/ANon-phased studies
3(14.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.0%

17 of 20 finished

Non-Completion Rate

15.0%

3 ended early

Currently Active

0

trials recruiting

Total Trials

21

all time

Status Distribution
Completed(17)
Terminated(3)
Other(1)

Detailed Status

Completed17
Terminated2
unknown1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
21
Active
0
Success Rate
89.5%
Most Advanced
Phase 4

Trials by Phase

Phase 18 (38.1%)
Phase 21 (4.8%)
Phase 35 (23.8%)
Phase 44 (19.0%)
N/A3 (14.3%)

Trials by Status

terminated210%
completed1781%
unknown15%
withdrawn15%

Recent Activity

Clinical Trials (21)

Showing 20 of 21 trialsScroll for more
NCT04451187Phase 1

A Study of Oral Seltorexant as an add-on Medication to an Antidepressant on On-road Driving Performance in Participants With Major Depressive Disorder

Completed
NCT05819710Phase 1

A Study to Investigate the Next-day Residual Effects of TS-142 in Healthy Elderly Subjects

Completed
NCT04696952Phase 1

A Study to Evaluate Next Day Effects of TS-142 on Driving Performance in Healthy Subjects

Completed
NCT06219902Phase 1

A Study to Learn if Elinzanetant Affects the Ability to Drive and Brain Function in Healthy Women

Completed
NCT03351439Not Applicable

Efficacy of Multimodal Analgesia Following Hip Arthroscopy

Completed
NCT02807922Phase 4

Pharmacological Treatment of Insomnia in Palliative Care

Completed
NCT02820441Phase 4

Benefit of One Month Zopiclone Intake on Adaptative Servoventilation Compliance

Terminated
NCT02732912Phase 3

SleepSure: A Trial to Assess the Effects of Eye Masks and Earplugs on Hospital Inpatient Sleep

Completed
NCT03339583Phase 2

Effectiveness of BBT-I and Zopiclone for Chronic Insomnia

Completed
NCT03632408Phase 1

Hangover and Residual Zopiclone Effect on Spatial Perception

Unknown
NCT02374567Phase 3

Pharmacovigilance in Gerontopsychiatric Patients

Terminated
NCT01311882Phase 1

A Study to Evaluate Next Day Effects of MK-4305 on Driving Performance (MK-4305-035 AM1)

Completed
NCT00798395Phase 1

A Study to Assess the Effect of Single and Multiple Doses Org 50081 and a Single Dose of Zopiclone on Next-day Driving Ability and Psychomotor Performance in Healthy Volunteers. (P05794) (COMPLETED)

Completed
NCT01100164Phase 3

A Non-inferiority Study With Two Treatment Arms Eszopiclone 3 mg Versus Zopiclone 7.5 mg - for the Treatment of Insomnia

Completed
NCT01369576Phase 3

Effect of Zopiclone on Compliance With Continuous Positive Airway Pressure in Obstructive Sleep Apnea

Completed
NCT01257165Not Applicable

Driving Simulator Performance After Intake of Zopiclone Sleeping Pills

Withdrawn
NCT01549691Phase 4

Reassessment of Premedication in Surgery

Completed
NCT00888342Not Applicable

Changes in Blood Gases, Disturbance of Breath During Sleep and Cardiovascular Co-morbidity in COPD Patients

Completed
NCT01106859Phase 1

Driving Performance After Middle of the Night Administration of 3.5 mg Zolpidem Tartrate Sublingual Tablet

Completed
NCT00237497Phase 3

Safety and Efficacy of Ramelteon in Adults With Chronic Insomnia

Completed

Drug Details

Intervention Type
DRUG
Total Trials
21